Influenza Pandemic Protection

 

Medi-Difenz specialises in delivering pandemic
protection measures


 
 
     
    Our Pandemic Services –
     
  Medical Expertise: Medical oversight and vital access to pandemic medication for all types of organisations
     
  Communication: Comprehensive staff pandemic communication strategy 
     
  Protection: Solutions for protection of both staff and family members
     
  Assessment: Bespoke online medical assessment process
     
 

Partnering: We partner with other occupational health companies to deliver our specialist service

 
Our Protection Solutions
 
 

Employee Pandemic Protection Scheme
Our approved occupational health scheme, screens all your employees for their suitability to antiviral medication and delivers the medication to your staff in advance of a possible severe pandemic.

 
 

Employees Family Protection
Many responsible employers recognise the priority of employees to protect their family in a pandemic. Our flexible medical screening process can include nominated family members.

 
 

Pandemic Flu Protection Kits
Our bespoke kits contain all the recommended protection and hygiene equipment that allows your employees to protect themselves in the workplace whilst offering assistance to an infected individual. We recommend one kit per location or per 25 staff members

 
 
 
 
 
  to learn more about our protection measures
     

Swine Flu News From Medical News Today

Latest Health News and Medical News posted throughout the day, every day.

NOVAVAX Completes Enrollment Of Pivotal H1N1 Influenza Vaccine Clinical Trial In Mexico
03/09/2010 09:00 AM
Novavax, Inc. (Nasdaq: NVAX) announced that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects...

Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
03/02/2010 08:00 AM
If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it...

Loyola Physician Discusses What Happened To The Flu
02/27/2010 09:00 AM
Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year. The number of states reporting widespread cases of the flu mysteriously plunged from 49 at the end of October to zero at the beginning of the January, according to the Centers for Disease Control and Prevention...

Also In Global Health News: Maternal, Child Health In Rwanda, Pakistan, India; Mongolia Weather; H1N1
02/26/2010 02:00 PM
Rwanda Targets Communities In Effort To Curb Maternal Mortality To reduce maternal mortality in Rwanda and reach U.N. Millennium Development Goal targets, the government will conduct maternal death audits in villages to help identify ways to improve outcomes, Rwanda's Minister of Health Richard Sezibera announced recently, the New Times/allAfrica.com reports...

Charles Manski Explores The Processes Of Making Public Policy Based On Limited Information
02/26/2010 01:00 PM
How might policymakers make reasonable decisions when they have limited information? That's the question Northwestern University's Charles F. Manski explores in his new paper, "Vaccination With Partial Knowledge of External Effectiveness." The paper is published online by the Proceedings of the National Academy of Sciences (PNAS) at http://www.pnas.org/content/early/2010/02/05/0915009107.full...

 
     
   

If you require more information: call Dominic on
0808 202 7729
email: dominic@medi-difenz.com

Medi-Difenz is part of the Medigold family of companies,
one the leading independent
occupational health providers in the UK